SOVREMENNAYA PEDIATRIYA.2016.8(80):116-122; doi 10.15574/SP.2016.80.116 

A new approach in the treatment of infants with functional disorders of the gastrointestinal tract

Berezhnoi V.V., Kozachuk V. G.

Shupik National Medical Academy of Postgraduate Education, Kiev, Ukraine

In the article the modern view on the pathogenesis of functional disorders of the gastrointestinal tract in children, accompanied by colic and flatulence is shown. According to the present studies for the last year was found that one of the major mechanisms of colic is a violation of intestinal microbiota. The main requirement for use of probiotics to infants is close to natural biocenosis with proven efficacy and safety. The unique composition of «Rotabiotik Baby» symbiotic allows to normalize intestinal microflora and to correct functional disorders of the gastrointestinal tract.

Key words: microbiota, children, colic, Rotabiotik Baby.

References

1. Andreeva IV. 2011. Sovremennyie dokazatelnyie dannyie effektivnosti primeneniya Lactobacillus Rhamnosus GG i Bifidobacterium Lactis VB-12 v pediatricheskoy praktike. Voprosyi sovr pediatrii. 10(1): 50—57.

2. Abaturov AE, Gerasimenko ON, Vyisochina IL et al. 2013. Bakteritsidnaya aktivnost probioticheskih sredstv. Zdorove rebenka. 8(51): 95—97.

3. Belmer SV. 2014. Korrektsiya narusheniy mikrobiotsenoza kishechnika. Effektivnaya farmakoterapiya. Pediatriya. 4(34).

4. Berdnikova EK. 2011. Funktsionalnyie kishechnyie koliki, taktika ih korrektsii u detey rannego vozrasta. Farmateka. 1: 60—65.

5. Berezhniy VV, Kozachuk VH. 2013. Pryrodne vyhodovuvannia. Pediatriia. Natsionalnyi pidruchnyk. Za red prof VV Berezhnoho. Kyiv. I: 278—287.

6. Berezhniy VV, Kozachuk VH. 2013. Pryrodne vyhodovuvannia. Pediatriia. Natsionalnyi pidruchnyk. Za red prof VV Berezhnoho. Kyiv. II: 517—529.

7. Berezhniy VV, Kozachuk VG. 2016. New features of the use of multistrain synbiotic in pediatric practice. Sovremennaya pediatriya. 1(72): 33—40; doi 10.15574/SP.2016.73.33

8. Voronenko YuV, Shekera OH, Berezhnyi VV. 2015. Aktualni pytannia pediatrii v praktytsi simeinoho likaria. Navchalnyi posibnyk dlia likariv interniv i likariv slukhachiv zakladiv (fakultetiv) pisliadyplomnoi osvity. Kyiv, Vydavets Zaslavskyi OIu: 342.

9. Zaharov IN, Dmitrieva YuA. 2013. Shtam-spetsificheskie svoystva Bifidobacterium animalis subsp. lactis Bb-12. Effektivnaya farmakoterapiya Pediatriya. 2.

10. Shadrin OG, Misnik VP, Ponomareva IG, Klimenko LA. 2014. On the question of formation of bowel eubiosis during the artifical infant feefing. Sovremennaya pediatriya. 1(57): 122—127.

11. Maidannyk VH. 2016. Rymski kryterii IV (2016), shcho novoho? Mizhnarodnyi zhurn pediatrii, akusherstva ta hinekolohii. 10(1): 10—18.

12. Mamenko ME. 2012. Mladencheskie kishechnyie koliki: sovremennyie podhodyi k terapii. Zdorove rebenka. 8: 99—102.

13. Shadryn OH, Niankovskyi SL, Beketova HV et al. 2016. Osoblyvosti diahnostyky ta pidkhody do likuvalno-profilaktychnoho kharchuvannia ditei rannoho viku z funktsionalnymy rozladamy travnoi systemy. Metodychni rekomendatsii. Kyiv,TOV «Liudy v bilomu»: 28.

14. Kornienko EA, Mazankova LN, Gorelov AV et al. 2015. Primenenie probiotikov v pediatrii: analiz lechebnogo i profilakticheskogo deystviya s pozitsiy dokazatelnoy meditsinyi. Lechaschiy vrach. 9: 52—61.

15. Pro zatverdzhennia protokoliv medychnoi dopomohy ditiam iz zakhvoriuvanniamy orhaniv travlennia. Nakaz MOZ Ukrainy 29.01.2013 № 59. http://www.moz.gov.ua.

16. Horoshilova NV. 2013. Immunomoduliruyuschee i lechebnoe deystvie bifido- i laktobakteriy u detey s allergicheskimi zabolevaniyami i chastyimi respiratornyimi infektsiyami. Voprosyi sovr pediatrii. 5: 86—89.

17. Yankovskiy DS. 2005. Mikrobnaya ekologiya cheloveka: sovremennyie vozmozhnosti ee podderzhanie i vosstanovleniya. Kiev, Ekspert LTD: 361.

18. Blyakher МS, Lopatina ТK, Zhukova VM. 2002. Vliyanie Probiotikov na Produktsiyu Interferonov i Limfokinov. Probioticheskie Mikroorganizmy — Sovremennoe Sostoyanie Voprosa i Perspektivy Ispol'zovaniya. Materialy Konferentsii. The Effect of Probiotics on the Production of Interferons and Lymphokines. Probiotic Microorganisms: The Present State and Prospects of Use. Proceedings of the Conference. Moscow: 29.

19. Aloisio I, Santini C, Biavati B et al. 2012. Characterization of Bifidobacterium spp. strains for the treatment of enteric disorders in newborns. Appl Microbiol Biotechnol. 96(6): 1561—76. https://doi.org/10.1007/s00253-012-4138-5. Epub 2012 May 17.

20. Rossi F, Marzotto M, Cremonese S et al. 2013. Diversity of Streptococcus thermophilus in bacteriocin production; inhibitory spectrum and occurrence of thermophilin genes. Food Microbiol. 35(1): 27—33; https://doi.org/10.1016/j.fm.2013.02.006.

21. Gronlund MM, Lehtonen OP, Eerola E, Kepo PJ. 1999. Fecal microflora in healthy infants born by different methods of delivery. Pediatr Gastroenterol Nutr. 28: 19-25. https://doi.org/10.1097/00005176-199901000-00007

22. Gill H, Prasad J. 2008. Probiotics, immunomodulation, and health benefits. Adv Exp Med Biol. 606: 423—547. https://doi.org/10.1007/978-0-387-74087-4_17; PMid:18183940

23. Novak FR, Almeida JAG, Vieira GO, Borba LM. 2001. Human colostrum: a natural source of probiotics? J Pediatr. 77(4): 265—270. https://doi.org/10.2223/JPED.233

24. Abedi D, Feizizadeh S, Akbari V, Jafarian-Dehkordi A. 2013. In vitro anti-bacterial and anti-adherence effects of Lactobacillus delbrueckii subsp bulgaricus on Escherichia coli. Res Pharm Sci 8(4): 260—8. PMid:24082895 PMCid:PMC3757591

25. Shimazaki Y, Shirota T, Uchida K et al. 2008. Intake of dairy product and periodontal diseases: The hisayama study. J Periodontol. 79: 131—137. https://doi.org/10.1902/jop.2008.070202; PMid:18166102

26. Karska-Wysocki B, Bazo M, Smoragiewicz W. 2010. Antibacterial activity of Lactobacillus acidophilus and Lactobacillus casei against methicillin-resistant Staphylococcus aureus (MRSA). Microbiol Res. 165(8): 674—86; https://doi.org/10.1016/j.micres.2009.11.008.

27. Kligler B. Cohrss A. 2008. Aliment Pharmacol Theren Probiotics. Am Fam Physician. 78: 1073—1078. PMid:19007054

28. Szajewska H, Horvath A, Piwowarczyk A. 2010. Meta-analysis: the effects of Saccharomyces boulardii supplementation on Helicobacter pylori eradication rates and side effects during treatment. Aliment Pharmacol Ther. 32(9): 1069—1079. https://doi.org/10.1111/j.1365-2036.2010.04457.x; PMid:21039671

29. Ohland CL, Macnaughton WK. 2010. Probiotic bacteria and ontestinal erithelial barrier function. Am J Physiol Gastrointest Liver Physiol. 298; 6: 807—819; doi 10/1152/ajpgi.00243.2009.

30. Dunne C, Murphy L, Flynn S et al. 1999. Probiotics: from myth to reality. Demonstration of functionality in animal models of disease and in human clinical trials. Antonie Van Leeuwenhoek. 76: 279—292. https://doi.org/10.1023/A:1002065931997; PMid:10532384

31. Proceedings of the International Scientific Conference on Probiotics and Prebiotics YPC2010. 2010. Kosice, Slovakia: 15.

32. Mkrtchyan H, Gibbons S, Heidelberger S et al. 2010. Purification, characterisation and identification of acidocin LCHV, an antimicrobial peptide produced by Lactobacillus acidophilus n.v. Er 317/402 strain Narine. Int J Antimicrob Agents. 35(3): 255—60; https://doi.org/10.1016/j.ijantimicag.2009.11.017.

33. Renye JAJr, Somkuti GA. 2013. BlpC-regulated bacteriocin production in Streptococcus thermophiles. Biotechnol Lett. 35(3): 407—12; https://doi.org/10.1007/s10529-012-1095-0.

34. Rerksuppaphol S, Rerksuppaphol L. 2012. Randomized controlled trial of probiotics to reduce common cold in schoolchildren. Pediatr Int. 54(5): 682—687. https://doi.org/10.1111/j.1442-200X.2012.03647.x; PMid:22507276

35. Rolfe RD. 2000. The role of probiotic cultures in the control of gastrointestinal health. J Nutr. 130; Suppl 2: 396—402.

36. Kianifar H, Ahanchian H, Grover Z et al. 2014. Synbiotic in the management of infantile colic: a randomised controlled trial. Paediавatr Child Health. 50(10): 801—5. doi 10.1111/jpc.12640. Epub 2014 Jun 24.